(R)-7-(3,4-Difluorobenzyl)-6-(methoxymethyl)-2-(5-methyl-2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)-6,7-dihydroimidazo[1,2-a]pyrazin-8(5H)-one

ID: ALA4482864

Cas Number: 2097416-76-5

PubChem CID: 129116690

Product Number: A414127, Order Now?

Max Phase: Preclinical

Molecular Formula: C24H24F2N8O2

Molecular Weight: 494.51

Molecule Type: Unknown

Associated Items:

This product is currently unavailable

Names and Identifiers

Canonical SMILES:  COC[C@H]1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)nc2C(=O)N1Cc1ccc(F)c(F)c1

Standard InChI:  InChI=1S/C24H24F2N8O2/c1-14-9-27-24(30-20-6-7-28-32(20)2)31-21(14)19-12-33-11-16(13-36-3)34(23(35)22(33)29-19)10-15-4-5-17(25)18(26)8-15/h4-9,12,16H,10-11,13H2,1-3H3,(H,27,30,31)/t16-/m1/s1

Standard InChI Key:  HVIGNZUDBVLTLU-MRXNPFEDSA-N

Molfile:  

 
     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
   31.2169  -22.9061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2158  -23.7297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9280  -24.1428    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.6418  -23.7293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6389  -22.9025    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.9262  -22.4972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3542  -24.1409    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.0654  -23.7271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8130  -24.0612    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.3588  -23.4490    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.9491  -22.7377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1460  -22.9090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9839  -24.8645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5050  -22.4977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9243  -21.6760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5880  -21.1895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2576  -21.1935    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.5077  -20.4114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3293  -20.4095    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.7382  -19.7004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3260  -18.9887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5044  -18.9906    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.0951  -19.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2737  -19.7073    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.0949  -18.2834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5025  -17.5710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3235  -17.5721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7352  -16.8605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3215  -16.1482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4959  -16.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0920  -16.8641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0830  -15.4468    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   32.7275  -15.4391    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   32.7332  -18.2802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5504  -18.2787    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.9577  -17.5702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  2  0
  9 13  1  0
  1 14  1  0
 15 16  2  0
 16 19  1  0
 18 17  2  0
 17 15  1  0
  6 15  1  0
 18 19  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 22 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 30 32  1  0
 29 33  1  0
 21 34  1  1
 34 35  1  0
 35 36  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK3 Tchem Mitogen-activated protein kinase; ERK1/ERK2 (651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K1 Tclin Dual specificity mitogen-activated protein kinase kinase 1 (4127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K2 Tclin Dual specificity mitogen-activated protein kinase kinase 2 (1262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAF1 Tclin Serine/threonine-protein kinase RAF (4169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK15 Tchem Mitogen-activated protein kinase 15 (766 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NUAK1 Tchem NUAK family SNF1-like kinase 1 (1769 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5 (3021 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E1 (1877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK3 Tchem MAP kinase ERK1 (4725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP3K8 Tchem Mitogen-activated protein kinase kinase kinase 8 (459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem CDK2/Cyclin O (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem CDK2/Cyclin A1 (171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Calu-6 (398 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 494.51Molecular Weight (Monoisotopic): 494.1990AlogP: 3.07#Rotatable Bonds: 7
Polar Surface Area: 102.99Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.64CX Basic pKa: 3.04CX LogP: 3.25CX LogD: 3.25
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.42Np Likeness Score: -1.64

References

1. Ward RA, Anderton MJ, Bethel P, Breed J, Cook C, Davies EJ, Dobson A, Dong Z, Fairley G, Farrington P, Feron L, Flemington V, Gibbons FD, Graham MA, Greenwood R, Hanson L, Hopcroft P, Howells R, Hudson J, James M, Jones CD, Jones CR, Li Y, Lamont S, Lewis R, Lindsay N, McCabe J, McGuire T, Rawlins P, Roberts K, Sandin L, Simpson I, Swallow S, Tang J, Tomkinson G, Tonge M, Wang Z, Zhai B..  (2019)  Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC).,  62  (24): [PMID:31710489] [10.1021/acs.jmedchem.9b01295]

Source